Alliance Pharma plc

Equities

APH

GB0031030819

Pharmaceuticals

Market Closed - London S.E. 09:05:27 19/09/2024 pm IST 5-day change 1st Jan Change
42.90 GBX +3.62% Intraday chart for Alliance Pharma plc +1.18% +5.93%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Alliance Pharma plc Announces Termination of Jeyan Heper as Director CI
EXECUTIVE CHANGES: New chief executives at Cornish Metals and ValiRx AN
HSS Hire Group's Interim CFO Takes Office MT
Alliance Pharma trading in line, revenue edges higher AN
Alliance Pharma nixes chief operating officer role AN
Alliance Pharma COO to Depart MT
Alliance Pharma plc Announces Jeyan Heper to Leave the Business as Chief Operating Officer, Effective 31 August 2024 CI
Alliance Pharma plc Announces Termination of Mr. Peter Jonathan Butterfield as Director CI
Alliance Pharma pays no dividend as board focus on reinvesting cash AN
Alliance Pharma plc, 2023 Earnings Call, Jun 19, 2024
Alliance Pharma plc Provides Preliminary Results for the Year Ended 31 December 2023 CI
Alliance Pharma plc Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Amberen, Brand of Alliance Pharma plc, Announces Launch of Amberen ENERGY MOOD SLEEP Gummies CI
Alliance Pharma plc Announces the Appointment of Nicholas John Sedgwick as Director CI
Alliance Pharma drops as CEO departs, delays results again AN
European Equities Close Higher in Wednesday Trading; Siemens Energy, Alliance Pharma CEOs to Step Down MT
Alliance Pharma Chief Executive to Leave; New CEO to Start May 13 MT
AIM WINNERS & LOSERS: Mobile Tornado wins deal; boohoo loss widens AN
Alliance Pharma plc Announces CEO Changes CI
Jefferies cuts AJ Bell; Deutsche likes ConvaTec AN
EARNINGS: Lok'n Store has "positive but muted" growth as Shurgard bids AN
Alliance Pharma plc Announces Delay in Publication of Preliminary Earnings Results for the Year Ended December 31, 2023 CI
Alliance Pharma appoints chair; FireAngel sales down AN
Alliance Pharma Chair to Step Down; Successor Named MT
Alliance Pharma plc Announces Board Changes CI
Chart Alliance Pharma plc
More charts
Logo Alliance Pharma plc
Alliance Pharma plc is a United Kingdom-based international consumer healthcare company. The principal activity of the Company is to act as a holding company. The principal activity of the Company is the acquisition, marketing and distribution of consumer healthcare and pharmaceutical products. Its segments include Consumer Healthcare brands and Prescription Medicines. Its Consumer Healthcare brands include the Kelo-Cote franchise, Amberen, Nizoral, MacuShield, Aloclair, Vamousse, and other consumer healthcare brands. Its Prescription Medicines include Hydromol, Flamma Franchise, Forceval and other prescription medicines. Its products include Aloclair Plus Gel, Aloclair Plus Spray, Aloclair Plus Mouthwash, Anbesol Adult Strength Gel, Anbesol Teething Gel, Anbesol Liquid, Atopiclair Cream, and Atopiclair Lotion. It holds marketing rights to around 80 consumer healthcare brands and prescription medicines, which are sold worldwide in more than 100 countries.
Employees
292
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
0.4290GBP
Average target price
0.6350GBP
Spread / Average Target
+48.02%
Consensus

Quarterly revenue - Rate of surprise